Florida Cancer Specialists Press Release

Dr. Estrella Carballido Joins Florida Cancer Specialists in Lee County

Fort Myers, FL – August 29, 2016……… Florida Cancer Specialists & Research Institute (FCS),the leading community oncology/hematology practice in the state, is pleased to announce that Estrella Carballido, MD has joined the practice and is seeing patients at three FCS locations in Lee County, FL. Dr. Carballido will practice at the Gladiolus Cancer Center, located at 8260 Gladiolus Drive, Fort Myers, FL, at the Cape Coral Cay West office, located at 1708 Cape Coral Parkway West, Suite 10, Cape Coral, FL and at the Colonial office, located at 8931 Colonial Center Drive, Suite 300, Fort Myers, FL.

FCS CEO Bradley Prechtl said, "Dr. Carballido will be able to add more convenience and expanded services for our patients in Lee County. She has a keen interest in clinical research and has been published in leading oncology journals. We are very pleased to have her join the FCS family.”

Dr. William Harwin, Founder and President of FCS, added, “Dr. Carballido is an outstanding physician who comes to us with excellent credentials. For the past several years, she has been teaching in Scottsdale, Arizona at the Mayo Clinic, a global leader in oncology that shares in our mission of providing world-class cancer treatment. Dr. Carballido will be a great addition to our network in Lee County.”


Estrella Carballido, MD
Medical Oncologist

After graduating Magna Cum Laude from medical school, Dr. Estrella Carballido completed her Internal Medicine Residency at the University of South Florida in Tampa, Florida. While there, she served as Chief Resident in the program. Dr. Carballido finished her fellowship in Oncology/Hematology at the Moffitt Cancer Center in Tampa, Florida, where she joined the faculty as an Assistant Member. Before coming to FCS, Dr. Carballido joined Mayo Clinic Cancer Center in Scottsdale, Arizona, one of the largest and most highly-regarded medical centers in the world and internationally recognized for its scientific excellence and focus on cancer prevention, diagnosis and treatment. There, she served as Assistant Professor of Medicine where she focused on genitourinary malignancies and melanoma.

Dr. Carballido has presented her clinical research findings at the American Society of Clinical Oncology (ASCO) national conferences. She has published several articles in peer-reviewed journals and abstracts in the prestigious Journal of Clinical Oncology. Dr. Carballido has special interests, and has been very active, in clinical research in bladder, kidney, renal pelvis and prostate cancer.

###


About Florida Cancer Specialists & Research Institute: (FLCancer.com)
Founded in 1984, Florida Cancer Specialists & Research Institute (FCS) is the largest independent medical oncology/hematology practice in the United States. With over 200 physicians, 150 nurse practitioners and physician assistants and over 90 locations in our network, we are committed to providing world-class cancer care in community-based settings close to home.

Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, FCS offers patients access to more clinical trials than any private oncology practice in Florida. 70% of new cancer drugs approved in 2015 for use in the U.S. were studied in clinical trials conducted with FCS participation*. Our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report. Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, M.D. Anderson, and Memorial Sloan-Kettering, the physicians of Florida Cancer Specialists provide leadership and consultation in the state's leading hospitals.

FCS serves patients on the Gulf Coast from Naples to the greater Tampa Bay area, north as far as Tallahassee, in Orlando and surrounding Central Florida communities, and on the East Coast in Daytona/Palm Coast, Vero Beach/Sebastian and in Palm Beach County.

Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research and cutting-edge technologies that help advance targeted treatments and genetically-based immunotherapies, and embodied by our outstanding team of highly-trained and dedicated physicians, clinicians and staff.

* Prior to approval

For More Information, Contact:
Florida Cancer Specialists Foundation & Research Institute
Shelly Glenn, Chief Marketing & Sales Officer -
770.365.6168

Chappell Roberts
Chris Wilkerson -
813.281.0088 ext. 315

Ganick Communications, Inc.
Elaine Ganick -
615.377.7877